Last updated on November 2018

To evaluate the efficacy of multiple dose levels of NYX-2925 versus placebo in treating the neuropathic pain associated with Diabetic Peripheral Neuropathy.

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Peripheral Neuropathy | Diabetic Neuropathy | Diabetic Peripheral Neuropathy | Neuropathy
  • Age: Between 18 - 70 Years
  • Gender: Male or Female

  • Have type 2 Diabetes
  • Be between the ages of 18-70
  • Hemoglobin A1c (HbA1c) ≤11%
  • Have diabetic peripheral neuropathy, of symmetrical nature and in lower extremities for more than 6 months to 10 years

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.